Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for lowering IOP. This study compared the safety a...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier España
2020-11-01
|
| Collection: | Clinics |
| Sujets: | |
| Accès en ligne: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100314&tlng=en |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|